Agonist Development Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agonist Development Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agonist Development Plan Today - Breaking & Trending Today

Liminal BioSciences Reports Fourth Quarter and Year Ended 2022 Financial Results

Published: March 15, 2023

CTA-enabling work on track to seek approval to commence Phase 1 clinical trial of LMNL6511 during the second half of 2023 Addition of GPR40 agonist discovery...

Source: prnewswire.com

Related Topics:

United KingdomPointe ClaireBruce PritchardNicole RusawAntagonist Development PlanAgonist Development PlanLiminal Biosciences IncNasdaq CapitalChief Financial OfficerGary BridgerInterim Chief Scientific OfficerChief Executive OfficerStrategic AdvisorInterim Chief ScientificNasdaq Capital MarketNasdaq Listing RuleYear Ended DecemberLiminal Biosciences Inc

Liminal BioSciences Reports Fourth Quarter and Year Ended 2022 Financial Results

Published: March 15, 2023

CTA-enabling work on track to seek approval to commence Phase 1 clinical trial of LMNL6511 during the second half of 2023 Addition of GPR40 agonist discovery...

Source: prnewswire.com

Related Topics:

United KingdomPointe ClaireKaitlin GallagherBruce PritchardNicole RusawShrinal InamdarExchange CommissionPrnewswire Liminal Biosciences IncAntagonist Development PlanSecurities ExchangeAgonist Development PlanLiminal Biosciences IncNasdaq CapitalChief Financial OfficerGary BridgerInterim Chief Scientific OfficerChief Executive OfficerStrategic AdvisorInterim Chief ScientificNasdaq Capital MarketNasdaq Listing RuleYear Ended DecemberSecurities ActSecurities Exchange ActLiminal Bioscience